CXSL2500041 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2025-01-14 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2300746 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2023-11-01 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2500335 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2025-04-28 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2400051 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2024-01-23 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2200555 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(1) | New Drug Application | 2022-11-02 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2400822 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2024-12-05 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2300581 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2023-08-30 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2500109 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2025-02-08 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2300838 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2023-12-05 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2400538 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2024-08-13 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2200199 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(1) | New Drug Application | 2022-05-07 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2500257 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2025-04-01 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2400048 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2024-01-22 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2400651 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2024-09-26 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CYSB2300098 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products | Supplementary Application | 2023-05-18 | | Shanghai Shengdi Pharmaceutical Co Ltd;Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CYSB2500036 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(1) | Supplementary Application | 2025-02-07 | | Shanghai Shengdi Pharmaceutical Co Ltd;Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CXSL2300834 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2023-12-01 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSB2400080 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(1) | Supplementary Application | 2024-07-30 | | Shanghai Shengdi Pharmaceutical Co Ltd;Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CXSL2200198 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(1) | New Drug Application | 2022-05-07 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |
CXSL2400913 | 阿得贝利单抗注射液 | Adebrelimab | Injection | Biological Products(2.2) | New Drug Application | 2024-12-27 | | Shanghai Shengdi Pharmaceutical Co Ltd | | | view |